Prestige Consumer Healthcare Free Cash Flow (FCF) History (PBH)
Prestige Consumer Healthcare reported $246.4M in free cash flow for fiscal 2026, an increase of 1.30% from the previous fiscal year, with a free cash flow margin of 22.64%.
View full Prestige Consumer Healthcare company overviewPrestige Consumer Healthcare free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2026 | 2026-03-31 | $246.4M | $3.2M | +1.30% | +22.64% |
| 2025 | 2025-03-31 | $243.3M | $3.9M | +1.64% | +21.38% |
| 2024 | 2024-03-31 | $239.4M | $17.4M | +7.86% | +21.27% |
| 2023 | 2023-03-31 | $221.9M | −$28.3M | −11.33% | +19.68% |
| 2022 | 2022-03-31 | $250.3M | $36.9M | +17.30% | +23.03% |
| 2021 | 2021-03-31 | $213.4M | $10.8M | +5.33% | +22.62% |
| 2020 | 2020-03-31 | $202.6M | $23.8M | +13.29% | +21.03% |
| 2019 | 2019-03-31 | $178.8M | −$18.8M | −9.50% | +18.32% |
| 2018 | 2018-03-31 | $197.6M | $51.9M | +35.61% | +18.98% |
| 2017 | 2017-03-31 | $145.7M | −$27.0M | −15.66% | +16.52% |
| 2016 | 2016-03-31 | $172.7M | $22.6M | +15.04% | +21.43% |
| 2015 | 2015-03-31 | $150.2M | $41.3M | +37.99% | +21.05% |
| 2014 | 2014-03-31 | $108.8M | −$18.5M | −14.54% | +18.27% |
| 2013 | 2013-03-31 | $127.3M | $60.5M | +90.49% | +20.64% |
| 2012 | 2012-03-31 | $66.8M | −$19.2M | −22.29% | +15.15% |
| 2011 | 2011-03-31 | $86.0M | $27.3M | +46.40% | +25.56% |
| 2010 | 2010-03-31 | $58.8M | — | — | +20.08% |
Prestige Consumer Healthcare quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | $67.1M | −$11.1M | −14.19% | +25.25% |
| Q4 2026 | 2026-03-31 | $37.6M | −$20.7M | −35.53% | +13.36% |
| Q3 2026 | 2025-12-31 | $75.3M | $11.7M | +18.47% | +26.55% |
| Q2 2026 | 2025-09-30 | $55.4M | −$12.4M | −18.28% | +20.20% |
| Q1 2026 | 2025-06-30 | $78.2M | $24.6M | +45.78% | +31.33% |
| Q4 2025 | 2025-03-31 | $58.4M | −$5.4M | −8.46% | +19.68% |
| Q3 2025 | 2024-12-31 | $63.5M | −$6.0M | −8.57% | +21.88% |
| Q2 2025 | 2024-09-30 | $67.8M | $8.2M | +13.85% | +23.88% |
| Q1 2025 | 2024-06-30 | $53.6M | $7.0M | +15.05% | +20.07% |
| Q4 2024 | 2024-03-31 | $63.8M | $7.3M | +13.00% | +23.02% |
| Q3 2024 | 2023-12-31 | $69.5M | $16.3M | +30.74% | +24.57% |
| Q2 2024 | 2023-09-30 | $59.5M | $4.4M | +7.91% | +20.79% |
| Q1 2024 | 2023-06-30 | $46.6M | −$10.6M | −18.51% | +16.69% |
| Q4 2023 | 2023-03-31 | $56.4M | −$3.5M | −5.90% | +19.74% |
| Q3 2023 | 2022-12-31 | $53.1M | −$10.9M | −17.06% | +19.29% |
| Q2 2023 | 2022-09-30 | $55.2M | −$3.3M | −5.61% | +19.07% |
| Q1 2023 | 2022-06-30 | $57.2M | −$10.6M | −15.64% | +20.65% |
| Q4 2022 | 2022-03-31 | $60.0M | $5.8M | +10.65% | +22.46% |
| Q3 2022 | 2021-12-31 | $64.1M | $20.6M | +47.29% | +23.34% |
| Q2 2022 | 2021-09-30 | $58.4M | $15.4M | +35.68% | +21.16% |
| Q1 2022 | 2021-06-30 | $67.8M | −$4.8M | −6.61% | +25.19% |
| Q4 2021 | 2021-03-31 | $54.2M | $3.6M | +7.05% | +22.79% |
| Q3 2021 | 2020-12-31 | $43.5M | −$11.3M | −20.57% | +18.22% |
| Q2 2021 | 2020-09-30 | $43.1M | −$3.3M | −7.08% | +18.14% |
| Q1 2021 | 2020-06-30 | $72.6M | $21.8M | +42.86% | +31.65% |
| Q4 2020 | 2020-03-31 | $50.6M | $3.1M | +6.56% | +20.15% |
| Q3 2020 | 2019-12-31 | $54.8M | $13.5M | +32.72% | +22.67% |
| Q2 2020 | 2019-09-30 | $46.4M | $9.7M | +26.49% | +19.47% |
| Q1 2020 | 2019-06-30 | $50.8M | −$2.6M | −4.80% | +21.89% |
| Q4 2019 | 2019-03-31 | $47.5M | −$4.1M | −7.87% | +19.71% |
| Q3 2019 | 2018-12-31 | $41.3M | −$996,000 | −2.36% | +17.09% |
| Q2 2019 | 2018-09-30 | $36.6M | −$15.5M | −29.77% | +15.31% |
| Q1 2019 | 2018-06-30 | $53.4M | $1.8M | +3.52% | +21.02% |
| Q4 2018 | 2018-03-31 | $51.6M | $45.1M | +695.46% | +20.14% |
| Q3 2018 | 2017-12-31 | $42.3M | $2.7M | +6.90% | +15.62% |
| Q2 2018 | 2017-09-30 | $52.2M | $2.9M | +5.92% | +20.23% |
| Q1 2018 | 2017-06-30 | $51.6M | $1.2M | +2.30% | +20.10% |
| Q4 2017 | 2017-03-31 | $6.5M | −$32.3M | −83.31% | +2.69% |
| Q3 2017 | 2016-12-31 | $39.5M | −$5.5M | −12.15% | +18.24% |
| Q2 2017 | 2016-09-30 | $49.3M | $3.1M | +6.73% | +22.91% |
| Q1 2017 | 2016-06-30 | $50.4M | $7.7M | +17.93% | +24.05% |
| Q4 2016 | 2016-03-31 | $38.8M | −$10.9M | −21.89% | +18.68% |
| Q3 2016 | 2015-12-31 | $45.0M | $240,000 | +0.54% | +22.48% |
| Q2 2016 | 2015-09-30 | $46.2M | $19.7M | +74.19% | +22.40% |
| Q1 2016 | 2015-06-30 | $42.7M | $13.6M | +46.50% | +22.25% |
| Q4 2015 | 2015-03-31 | $49.7M | $19.1M | +62.37% | +26.32% |
| Q3 2015 | 2014-12-31 | $44.8M | $19.8M | +79.61% | +22.65% |
| Q2 2015 | 2014-09-30 | $26.5M | −$5.3M | −16.78% | +14.62% |
| Q1 2015 | 2014-06-30 | $29.2M | $7.7M | +36.12% | +20.02% |
| Q4 2014 | 2014-03-31 | $30.6M | −$4.8M | −13.47% | +21.67% |
| Q3 2014 | 2013-12-31 | $24.9M | −$11.9M | −32.36% | +17.20% |
| Q2 2014 | 2013-09-30 | $31.8M | −$9.7M | −23.38% | +19.08% |
| Q1 2014 | 2013-06-30 | $21.4M | $7.9M | +58.25% | +15.04% |
| Q4 2013 | 2013-03-31 | $35.4M | $16.2M | +84.18% | +23.93% |
| Q3 2013 | 2012-12-31 | $36.8M | $22.4M | +154.53% | +23.00% |
| Q2 2013 | 2012-09-30 | $41.6M | $23.8M | +133.61% | +25.68% |
| Q1 2013 | 2012-06-30 | $13.5M | −$1.8M | −11.86% | +9.21% |
| Q4 2012 | 2012-03-31 | $19.2M | −$5.5M | −22.41% | +14.34% |
| Q3 2012 | 2011-12-31 | $14.5M | −$4.2M | −22.55% | +13.62% |
| Q2 2012 | 2011-09-30 | $17.8M | −$4.2M | −19.05% | +16.86% |
| Q1 2012 | 2011-06-30 | $15.4M | −$5.2M | −25.34% | +16.13% |
| Q4 2011 | 2011-03-31 | $24.8M | — | — | +25.70% |
| Q3 2011 | 2010-12-31 | $18.7M | — | — | +20.63% |
| Q2 2011 | 2010-09-30 | $22.0M | — | — | +28.07% |
| Q1 2011 | 2010-06-30 | $20.6M | — | — | +28.89% |
Prestige Consumer Healthcare free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from $213.4M to $246.4M, a compound annual growth rate of 2.93%. Prestige Consumer Healthcare's latest reported quarter, Q1 2027, generated $67.1M in free cash flow, a decrease of 14.19% year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Prestige Consumer Healthcare filings at SEC.gov ↗